# Esanex, Inc.: Form D filings

Esanex, Inc., a pharmaceuticals company in Indianapolis, IN, filed 4 Form D notices with the SEC between 2012 and 2017. The latest, on April 10, 2017, reports $2.6 million sold of a $2.9 million offering to 4 investors.

Find out what Esanex, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Esanex%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Esanex%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fesanex-inc-1531658)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Esanex%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Esanex%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fesanex-inc-1531658)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Indiana](https://specstream.ai/data/form-d/state/indiana): 436 rows, by operating companies, filed since November 1, 2024, $21.80, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/indiana
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 115 W. WASHINGTON ST., SUITE 1680 - SOUTH, Indianapolis, IN, 46204
- Phone: (317) 429-0143
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1531658

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 10, 2017 | New notice | $2,900,000 | $2,584,161 | $315,839 | 4 | Mar 27, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1531658/000153165817000001/0001531658-17-000001-index.htm) |
| Dec 12, 2012 | Amendment | $15,500,000 | $15,500,000 | $0 | 4 | Apr 16, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1531658/000153165812000003/0001531658-12-000003-index.htm) |
| Jun 13, 2012 | Amendment | $15,500,000 | $4,753,336 | $10,746,664 | 4 | Apr 16, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1531658/000153165812000002/0001531658-12-000002-index.htm) |
| Apr 26, 2012 | New notice | $15,000,000 | $4,600,002 | $10,399,998 | 3 | Apr 16, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1531658/000153165812000001/0001531658-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Steven E Hall | Executive Officer, Director |  |
| Richard Edward Miller | Director |  |
| S Edward Torres | Executive Officer |  |
| Richard Edward Kent | Director |  |

[Every Form D from the week of Apr 10, 2017](https://specstream.ai/data/form-d/week/2017-04-10) · [All recent filings in Indiana](https://specstream.ai/data/form-d/state/indiana) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Esanex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).